Larvol Delta - Harbour-BioMedannounced-that-the-National-Medical-Products-Administration-NMPA-of-China-has-approved-the-Investigational-New-Drug-IND-application-for-HBM7004-for-the-treatment-of-advanced-solid-tumors

HBM7004 - Harbour BioMed

Harbour BioMed...announced that the National Medical Products Administration (NMPA) of China has approved the Investigational New Drug (IND) application for HBM7004 for the treatment of advanced solid tumors. (PRNewswire) Aug 18, 2026
New trial • Solid Tumor

https://www.prnewswire.com/news-releases/harbour-biomed-announces-nmpa-approval-of-ind-application-for-hbm7004-for-the-treatment-of-advanced-solid-tumors-302853916.html

Aug 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next